Getting better, still room for growth but better then big pharma - Research Associate III Regeneron Employee Review

4.0
Dec 28, 2011
Recommend
CEO approval
Business Outlook

Pros

Job security relatively safe which is a nice change from the constant lay offs at big pharma. Compensation is improving with the recent drug approval. Laid back atmosphere, lots of parties (although the ones on site now have 2 beer max, again not horrible). Overall everyone seems to be happy

Cons

Biggest complain is compensation and fairness in performance evaluations. If they improve this I think overall morale will be higher. Also a clear path in terms what is expected to grow/get promoted would be nice

Explore other reviews about Regeneron

5.0
Jun 27, 2026
Recommend
CEO approval
Business Outlook

Pros

Great community and experience catered to your professional level. Very good for your first internship.

Cons

Not as advanced in the machine learning and AI fields.

3.0
Jun 22, 2026
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Good pay and benefits. Flexibility of work hours.

Cons

If you're in the wrong group, it's a struggle to get autonomy even when you ask for more oversight of a group or project because micromanaging is an issue. I feel trapped where I am and growth has been stagnant. They also hold a mistake against you for years. Management afraid to give constructive criticism.

See reviews by: Helpful|Rating|Date|All